HIGHLIGHTS
- who: Maria Gu00f3mez-Herranz and colleagues from the Institute of Genetics and Cancer, University of Edinburgh, Edinburgh , XU, UK have published the research work: Emergent Role of IFITM1/3 towards Splicing Factor (SRSF1) and Antigen-Presenting Molecule (HLA-B) in Cervical Cancer, in the Journal: Biomolecules 2022, 12, 1090. of /2022/
- what: The authors investigate new protein-protein interactions for IFITM1/3 in the context of cancer that would shed some light on how IFITM1/3 attenuate the expression of targeted proteins such as SBP-tagged IFITM1 protein was used to identify an association of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.